Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12605000732684
Ethics application status
Approved
Date submitted
12/09/2005
Date registered
11/11/2005
Date last updated
11/11/2005
Type of registration
Retrospectively registered

Titles & IDs
Public title
Analysis of angiogenesis markers, circulating tumour, endothelial progenitor, endothelial, dendritic, T and B cells in women receiving adjuvant chemotherapy for early breast cancer
Scientific title
Analysis of angiogenesis markers, circulating tumour, endothelial progenitor, endothelial, dendritic, T and B cells in women receiving adjuvant chemotherapy for early breast cancer.
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Breast Cancer 884 0
Condition category
Condition code
Cancer 952 952 0 0
Breast

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Not applicable.
Intervention code [1] 466 0
Diagnosis / Prognosis
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 1250 0
To establish techniques in order to plan future clinical correlative studies
Timepoint [1] 1250 0
Primary outcome [2] 1251 0
To establish technical variables in order to plan future clinical correlative studies
Timepoint [2] 1251 0
Secondary outcome [1] 2278 0
Nil
Timepoint [1] 2278 0

Eligibility
Key inclusion criteria
Patients receiving adjuvant chemotherapy for early breast cancer.
Minimum age
Not stated
Maximum age
Not stated
Sex
Females
Can healthy volunteers participate?
No
Key exclusion criteria
No exclusion criteria

Study design
Purpose
Screening
Duration
Cross-sectional
Selection
Convenience sample
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
1/10/2005
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
50
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 1050 0
Hospital
Name [1] 1050 0
Mater Hospital
Country [1] 1050 0
Australia
Primary sponsor type
Hospital
Name
Mater Adult hospital
Address
Country
Australia
Secondary sponsor category [1] 911 0
None
Name [1] 911 0
N/A
Address [1] 911 0
Country [1] 911 0

Ethics approval
Ethics application status
Approved

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 35641 0
Address 35641 0
Country 35641 0
Phone 35641 0
Fax 35641 0
Email 35641 0
Contact person for public queries
Name 9655 0
Ken Musgrave
Address 9655 0
Mater Adult Hospital
Raymond Tce
South Brisbane QLD 4101
Country 9655 0
Australia
Phone 9655 0
+61 7 38408697
Fax 9655 0
+61 7 38402834
Email 9655 0
Ken.Musgrave@mater.org.au
Contact person for scientific queries
Name 583 0
Associate Professor P.Mainwaring
Address 583 0
Mater Adult Hospital
Raymond Tce
South Brisbane QLD 4101
Country 583 0
Australia
Phone 583 0
+61 7 38406166
Fax 583 0
+61 7 38402834
Email 583 0
Paul.Mainwaring@mater.org.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.